News
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.
The Food and Drug Administration approved a new vaccine to prevent HIV infection, lenacapavir, a long-acting injection, which ...
Audacy on MSN6h
There's a new, highly effective HIV drug on the marketA revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and ...
Gilead's FDA-approved Yeztugo, a twice-yearly injectable HIV PrEP, showed near-perfect trial efficacy but faces backlash over ...
The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV. The drug, called Yeztugo from company Gilead Sciences, was approved Wednesday ...
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback